Authors, Years | Pathogens | Matrix | Sample size | Methodology | References |
---|---|---|---|---|---|
Viruses and bacteria | |||||
Bu et al., 2014 | HSV-1, CMV, Borrelia burgdorferi, Chlamydia pneumoniae, Helicobacter pylori | Serum | 128 AD | ELISA | [15] |
Strandberg et al., 2003 | HSV-1, HSV-2, CMV, Chlamydia pneumoniae, Mycoplasma pneumoniae | Serum | 383 | ELISA | [52] |
Strandberg et al., 2005 | HSV-1, HSV-2, CMV, Chlamydia pneumoniae, Mycoplasma pneumoniae, Helicobacter pylori | Serum | 58 | ELISA, PCR-based analysis | [53] |
Katan et al., 2013 | HSV-1, HSV-2, CMV, Chlamydia pneumoniae, Helicobacter pylori | Serum | 1625 | ELISA | [54] |
Wright et al., 2015 | HSV-1, HSV-2, CMV, Chlamydia pneumoniae, Helicobacter pylori | Serum | 588 | ELISA | [55] |
Renvoize et al., 1987 | HSV-1, CMV, Adenovirus, Influenza A and B, Measles Chlamydia Group B, Coxiella burnettii, Mycoplasma pneumoniae | Serum | 33 AD | Immunochemical analysis | [56] |
Viruses and parasites | |||||
Gale et al., 2016 | CMV, HSV-1, HSV-2 Toxocaris, Toxoplasmosis, Hepatitis A, B, C | Serum | 5662 | Immunochemical analysis | [66] |
Nimgaonkar et al., 2016 | HSV-1, HSV-2, CMV, Toxoplasma gondii | Serum | 1022 | Immunochemical analysis | [67] |
Viruses and fungi | |||||
Kuboshima et al., 2007 | CMV, Aspergilloma | Lungs | 1 AD | Autopsy | [68] |
Bacteria and parasites | |||||
Gale et al., 2015 | Helicobacter pylori, Toxoplasma gondii | Serum | 1785 | Immunochemical analysis | [69] |
Bacteria and fungi | |||||
Alonso et al., 2018 | Several bacterial and fungal species | Brain | 10 AD | Immunochemical analysis, PCR-based analysis, NGS | [14] |
Bacteria, viruses, and fungi | |||||
Pisa et al., 2018 | NC | Brain | 2 AD | Immunochemical analysis, PCR-based analysis, Proteomic analysis | [19] |
Bacteria, viruses, fungi, and parasites | |||||
Pisa et al., 2017 | NC | Brain | 10 AD | Immunochemical analysis, PCR-based analysis | [20] |